Scott MacDonald
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Scott MacDonald has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Eugenia Oviedo-Joekes
School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, Canada
2 shared publications - Heather Palis
Harm Reduction and Substance Use Services, BCCDC
2 shared publications - Kirsten Marchand
Centre for Health Evaluation and Outcome Sciences, Providence Health Care and University of British Columbia, Vancouver, Canada
2 shared publications - Amanda Slaunwhite
BC Centre for Disease Control, Vancouver, Canada
1 shared publication Chloé G. Xavier
BC Centre for Disease Control, 655 W 12th Avenue, Vancouver, BC, V5Z 4R4, Canada
1 shared publication- Daphne Guh
Centre for Advancing Health Outcomes, Providence Research , Vancouver, BC V6Z 1Y6
1 shared publication
Latest Publications
- Open Access
- 16 April 2025
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 45, 101097
Interpreting trends of opioid and stimulant co-prescribing in the United States: the need for attention to evidence-based prescribing practice in the context of co-occurring mental and or substance use disorders
- 16 April 2025
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 45, 101097
Open AccessInterpreting trends of opioid and stimulant co-prescribing in the United States: the need for attention to evidence-based prescribing practice in the context of co-occurring mental and or substance use disorders
- 29 December 2022
- Published by Elsevier in International Journal of Drug Policy
- Vol. 112, 103948
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)
- 29 December 2022
- Published by Elsevier in International Journal of Drug Policy
- Vol. 112, 103948
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)
- 6 February 2020
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 14 (6) , 480-488
Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool
Objective: Patient ratings of physician communication in the setting of daily injectable opioid agonist treatment are reported. Associations between communication items and demographic, health, drug use, and treatment characteristics are explored. Methods: Participants (n = 121) were patients receiving treatment for opioid use disorder with hydromorphone (an opioid analgesic) or diacetylmorphine (medical grade heroin). Ratings of physician communication were collected using the 14-item Communication Assessment Tool. Items were dichotomized and associations were explored using univariate and multivariable logistic regression models for each of the 14 items. Results: Ratings of physician communication were lower than reported in other populations. In nearly all of the 14 multivariable models, participants with more physical health problems and with lower scores for treatment drug liking had lower odds of rating physician communication as excellent. Conclusions: In physician interactions with patients with opioid use disorder, there is a critical need to address comorbid physical health problems and account for patient medication preferences. Practice Implications: Findings reinforce the role physicians can play in communicating with patients about their comorbid conditions and about medication preferences. In the patient-physician interaction efforts to meet patients’ evolving treatment needs and preferences can be made by offering patients access to all available evidence-based treatments.
- 6 February 2020
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 14 (6) , 480-488
Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool
Objective: Patient ratings of physician communication in the setting of daily injectable opioid agonist treatment are reported. Associations between communication items and demographic, health, drug use, and treatment characteristics are explored. Methods: Participants (n = 121) were patients receiving treatment for opioid use disorder with hydromorphone (an opioid analgesic) or diacetylmorphine (medical grade heroin). Ratings of physician communication were collected using the 14-item Communication Assessment Tool. Items were dichotomized and associations were explored using univariate and multivariable logistic regression models for each of the 14 items. Results: Ratings of physician communication were lower than reported in other populations. In nearly all of the 14 multivariable models, participants with more physical health problems and with lower scores for treatment drug liking had lower odds of rating physician communication as excellent. Conclusions: In physician interactions with patients with opioid use disorder, there is a critical need to address comorbid physical health problems and account for patient medication preferences. Practice Implications: Findings reinforce the role physicians can play in communicating with patients about their comorbid conditions and about medication preferences. In the patient-physician interaction efforts to meet patients’ evolving treatment needs and preferences can be made by offering patients access to all available evidence-based treatments.
- Open Access
Reply to Beckson et al. (2019): Cannabis, crashes, and blood: challenges for observational research
- 7 May 2015
- Published by Wiley in The Journal of Rural Health
- Vol. 31 (4) , 335-345
Alcohol, Isolation, and Access to Treatment: Family Physician Experiences of Alcohol Consumption and Access to Health Care in Rural British Columbia
Objective: The purpose of this project was to study the experiences of physicians who treat persons with alcohol‐attributed diseases in rural areas of British Columbia, Canada.Method: A cross‐sectional survey was distributed to primary health care physicians that had a family practice in a designated rural community using the Rural Coordination Centre of British Columbia's community isolation rating system. Data were collected through a mail and online survey sent to primary health care physicians. Purposeful sampling was used to select participants that had a primary health care practice in a designated rural community.Results: Surveys were returned by 22% of potential participants (N = 67) that had an average of 15.8 years in family practice. The majority of participants (95.4%) reported that alcohol had a negative impact on population health, and physicians expressed particular concern for alcohol consumption in relation to mental health (85.1%) and physical illness (82.1%). Most participants had referred patients out of the community for treatment; however, 76.4% reported difficulty with referrals, including long wait‐lists, limited services, and issues related to transportation and leaving the community for substance use treatment.Conclusion: Rural physicians showed an awareness and concern for alcohol consumption in their community, but they also reported difficulties referring patients for substance use treatment. Additional study is required to understand how to improve the continuity of care provided to persons with alcohol‐related issues in rural British Columbia.
- 7 May 2015
- Published by Wiley in The Journal of Rural Health
- Vol. 31 (4) , 335-345
Alcohol, Isolation, and Access to Treatment: Family Physician Experiences of Alcohol Consumption and Access to Health Care in Rural British Columbia
Objective: The purpose of this project was to study the experiences of physicians who treat persons with alcohol‐attributed diseases in rural areas of British Columbia, Canada.Method: A cross‐sectional survey was distributed to primary health care physicians that had a family practice in a designated rural community using the Rural Coordination Centre of British Columbia's community isolation rating system. Data were collected through a mail and online survey sent to primary health care physicians. Purposeful sampling was used to select participants that had a primary health care practice in a designated rural community.Results: Surveys were returned by 22% of potential participants (N = 67) that had an average of 15.8 years in family practice. The majority of participants (95.4%) reported that alcohol had a negative impact on population health, and physicians expressed particular concern for alcohol consumption in relation to mental health (85.1%) and physical illness (82.1%). Most participants had referred patients out of the community for treatment; however, 76.4% reported difficulty with referrals, including long wait‐lists, limited services, and issues related to transportation and leaving the community for substance use treatment.Conclusion: Rural physicians showed an awareness and concern for alcohol consumption in their community, but they also reported difficulties referring patients for substance use treatment. Additional study is required to understand how to improve the continuity of care provided to persons with alcohol‐related issues in rural British Columbia.
- 27 October 2012
- Published by Springer Nature in International Journal of Mental Health and Addiction
- Vol. 11 (2) , 162-171
The Role of Psychosocial Characteristics in Criminal Convictions Among Cocaine and Gambling Clients in Treatment
- 27 October 2012
- Published by Springer Nature in International Journal of Mental Health and Addiction
- Vol. 11 (2) , 162-171
The Role of Psychosocial Characteristics in Criminal Convictions Among Cocaine and Gambling Clients in Treatment